Tag: publication bias

Experts advocate limiting antidepressant use to only the most severe cases of depression, emphasizing the need for social and psychological interventions.

The published literature is misleading, as the negative Xanax trials either went unpublished or were spun to appear positive.

Selective publication bias in top psychiatry journals was not explained by the quality of the studies, but by financial ties to pharma.

Ayurdhi Dhar interviews Erick Turner about publication bias in antidepressant trials, compromised psychotherapeutic research, and a culture of journal worship.

Antidepressant trials with negative results are still more likely than not to either be misleadingly spun as positive or unpublished.

A new study, published in Psychological Medicine, found evidence for a specific type of publication bias distorting the evidence about antidepressant efficacy.

A new study finds that sponsors of clinical trials in the EU continue to fail at reporting their results as required by recent legislation.

From Science Alert: "It's no secret that scientists can be corrupted — in the past, researchers have purposefully hidden data on climate change, and the...

Dr. Johnathan Shedler recently published a paper critiquing how the term “evidence-based” is being used in the field of psychotherapy.

New research shows that more connected and well-known researchers are more likely to be published, even when they receive negative reviews.

Scientists at the Yale Collaboration for Research Integrity and Transparency (CRIT) published a new policy paper this month criticizing the current state of biomedical research and calling for improved transparency in research methods.

A new study in the journal Translational Psychiatry, an influential journal in biological psychiatry published by Nature, challenges the state of the research on antipsychotic drugs.

Sheila Kaplan for the Boston Globe reports that Dr. Robert Califf, the Obama administration's nominee to lead the Food and Drug Administration (FDA), has removed his name from a series of scientific papers that he recently coauthored. The decision to remove his name, against publication ethics standards, has brought Califf under renewed criticism.

While publication bias has been known to overestimate the efficacy of antidepressant treatments, a new study suggests that research on the use of psychotherapy in depression suffers from a similar bias.